Special Commission on the Public Health Effects of Xylazine Final Report

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 1 Sponsors

Report of the Special Commission on Public Health Effects of Xylazine (pursuant to Section 36 of Chapter 285 of the Acts of 2024) submitting its recommendations and final report on ways to address the public health and safety concerns posed by the proliferation of xylazine as an additive to illicit drugs including, but not limited to, fentanyl

Chamber: Senate
Introduced: Mar 30, 2026
Last action: Mar 30, 2026 — Placed on file
Session: 194th
Momentum: 14 · Stalled

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Introduced — base rate 3%, measured from MA's completed sessions
Momentum -8 14/100 from the pace of recorded action
Time since last action -22 198 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.